Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.

Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.

Item
http://www.wikidata.org/entity/Q37235742
Bone-cartilage crosstalk: a conversation for understanding osteoarthritisMechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis painActivation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress.Low‑dose halofuginone inhibits the synthesis of type I collagen without influencing type II collagen in the extracellular matrix of chondrocytes.Increased 15-lipoxygenase-1 expression in chondrocytes contributes to the pathogenesis of osteoarthritis.Progranulin derivative Atsttrin protects against early osteoarthritis in mouse and rat models.Isoliquiritigenin suppresses IL-1β induced apoptosis and inflammation in chondrocyte-like ATDC5 cells by inhibiting NF-κB and exerts chondroprotective effects on a mouse model of anterior cruciate ligament transection.Isoliquiritigenin blunts osteoarthritis by inhibition of bone resorption and angiogenesis in subchondral bone.Local delivery of tetramethylpyrazine eliminates the senescent phenotype of bone marrow mesenchymal stromal cells and creates an anti-inflammatory and angiogenic environment in aging mice.Halofuginone Attenuates Osteoarthritis by Rescuing Bone Remodeling in Subchondral Bone Through Oral Gavage.Differential Role of Transforming Growth Factor-beta in an Osteoarthritic or a Healthy Joint.
P2860

Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.

Item
http://www.wikidata.org/entity/Q37235742
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Halofuginone attenuates osteoa ...... formation in subchondral bone.
@en
Halofuginone attenuates osteoa ...... formation in subchondral bone.
@nl
type
label
Halofuginone attenuates osteoa ...... formation in subchondral bone.
@en
Halofuginone attenuates osteoa ...... formation in subchondral bone.
@nl
prefLabel
Halofuginone attenuates osteoa ...... formation in subchondral bone.
@en
Halofuginone attenuates osteoa ...... formation in subchondral bone.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Halofuginone attenuates osteoa ...... formation in subchondral bone
@en
P2093
P2860
P304
P31
P356
10.1136/ANNRHEUMDIS-2015-207923
P407
P433
P478
P50
P577
P5875
P698
P921
P932